JUBLPHARMA

Regulatory Overhang Cleared!

's US subsidiary Cadista facility receives EIR with VAI status from the USFDA – a key regulatory win! ✅ This means the inspection is successfully closed with no critical issues, clearing regulatory uncertainty. 📈 What this means for the stock: ✔️Short-term positive sentiment, but watch price action for confirmation. ✔️Long-term, this strengthens US market presence, reducing compliance risks.